Sponsor or institution

Clinical trials and research at Eikon Therapeutics

• 5Clinical trials
• 28Countries

Newest trials

All recruiting trials (5)

• EIK1001 with pembrolizumab and chemotherapy in stage 4 non-small cell lung cancer

  This study tests whether adding EIK1001 to pembrolizumab plus standard chemotherapy can help people with stage 4 NSCLC.

  Recruiting at 42 sites Phase 2/3 Eikon Therapeutics · Daphne, Alabama and 41 other locations · NCT07365319

• EIK1005 (Werner helicase inhibitor) alone or with pembrolizumab for advanced MSI-H/dMMR and other solid tumors

  This trial tests whether EIK1005, given alone or together with pembrolizumab, can be safely given and help people with advanced solid tumors, especially MSI‑H/dMMR cancers.

  Recruiting at 44 sites Phase 1/2 Eikon Therapeutics · Los Angeles, California and 44 other locations · NCT07262619

• Evaluating EIK1004 for Advanced Solid Tumors

  This study is testing a new drug called EIK1004 to see if it is safe and effective for people with advanced solid tumors like breast, ovarian, prostate, and pancreatic cancers who have certain genetic mutations.

  Recruiting at 10 sites Phase 1/2 Eikon Therapeutics · Denver, Colorado and 9 other locations · NCT06907043

• Evaluating EIK1001 with Pembrolizumab for Advanced Melanoma

  This study is testing if a new drug called EIK1001, when combined with Pembrolizumab, can help people with advanced melanoma feel better compared to just using Pembrolizumab alone.

  Recruiting at 125 sites Phase 2/3 Eikon Therapeutics · Chandler, Arizona and 126 other locations · NCT06697301

• Testing a new drug, IMP1734, for advanced solid tumors

  This study is testing a new drug called IMP1734 to see if it can safely help people with advanced solid tumors like breast, ovarian, and prostate cancer.

  Recruiting at 46 sites Phase 1/2 Eikon Therapeutics · Tucson, Arizona and 56 other locations · NCT06253130

Quick answers

How many clinical trials run by Eikon Therapeutics are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 28 countries. The most sites are in Australia (5 trials), United States (5 trials), South Korea (4 trials), Spain (4 trials), France (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →